Literature DB >> 12825461

P2Y receptors: biological advances and therapeutic opportunities.

S R Shaver1.   

Abstract

The P2 family of membrane-bound receptors is activated by naturally occurring nucleotides. When activated, these widely distributed receptors elicit cellular signaling which mediate multiple tissue-specific effects throughout the body. P2X receptors are ligand-gated ionotropic channels, while P2Y receptors belong to the superfamily of metabotropic G protein-coupled receptors. To date, there are six human cloned and functionally characterized subtypes of the P2Y family: P2Y1, P2Y2, P2Y4, P2Y6, P2Y11 and P2Y12. There exists enough agonist specificity between receptor subtypes to allow functional identification of newly found putative receptors. There are few specific antagonists of the P2Y receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12825461

Source DB:  PubMed          Journal:  Curr Opin Drug Discov Devel        ISSN: 1367-6733


  11 in total

1.  Structure-activity relationships of uridine 5'-diphosphate analogues at the human P2Y6 receptor.

Authors:  Pedro Besada; Dae Hong Shin; Stefano Costanzi; Hyojin Ko; Christophe Mathé; Julien Gagneron; Gilles Gosselin; Savitri Maddileti; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2006-09-07       Impact factor: 7.446

2.  ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells.

Authors:  Edward C Y Wang; Jey-Myung Lee; Wily G Ruiz; Elena M Balestreire; Maximilian von Bodungen; Stacey Barrick; Debra A Cockayne; Lori A Birder; Gerard Apodaca
Journal:  J Clin Invest       Date:  2005-08-18       Impact factor: 14.808

3.  Structure-activity relationship of uridine 5'-diphosphoglucose analogues as agonists of the human P2Y14 receptor.

Authors:  Hyojin Ko; Ingrid Fricks; Andrei A Ivanov; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2007-04-04       Impact factor: 7.446

4.  Noradrenaline and extracellular nucleotide cotransmission involves activation of vasoconstrictive P2X(1,3)- and P2Y6-like receptors in mouse perfused kidney.

Authors:  Oliver Vonend; Johannes Stegbauer; Johann Sojka; Sina Habbel; Ivo Quack; Bernard Robaye; Jean-Marie Boeynaems; Lars Christian Rump
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

Review 5.  P2Y receptors in the mammalian nervous system: pharmacology, ligands and therapeutic potential.

Authors:  Gary A Weisman; Lucas T Woods; Laurie Erb; Cheikh I Seye
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-09       Impact factor: 4.388

Review 6.  P2 receptors for extracellular nucleotides in the central nervous system: role of P2X7 and P2Y₂ receptor interactions in neuroinflammation.

Authors:  Gary A Weisman; Jean M Camden; Troy S Peterson; Deepa Ajit; Lucas T Woods; Laurie Erb
Journal:  Mol Neurobiol       Date:  2012-04-01       Impact factor: 5.590

7.  Human P2Y(14) receptor agonists: truncation of the hexose moiety of uridine-5'-diphosphoglucose and its replacement with alkyl and aryl groups.

Authors:  Arijit Das; Hyojin Ko; Lauren E Burianek; Matthew O Barrett; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

8.  Molecular recognition in the P2Y(14) receptor: Probing the structurally permissive terminal sugar moiety of uridine-5'-diphosphoglucose.

Authors:  Hyojin Ko; Arijit Das; Rhonda L Carter; Ingrid P Fricks; Yixing Zhou; Andrei A Ivanov; Artem Melman; Bhalchandra V Joshi; Pavol Kovác; Jan Hajduch; Kenneth L Kirk; T Kendall Harden; Kenneth A Jacobson
Journal:  Bioorg Med Chem       Date:  2009-05-15       Impact factor: 3.641

9.  Extracellular ATP is a danger signal activating P2X7 receptor in a LPS mediated inflammation (ARDS/ALI).

Authors:  Sanja Cicko; Thomas Christian Köhler; Cemil Korcan Ayata; Tobias Müller; Nicolas Ehrat; Anja Meyer; Madelon Hossfeld; Andreas Zech; Francesco Di Virgilio; Marco Idzko
Journal:  Oncotarget       Date:  2018-07-17

Review 10.  Signalling molecules in the urothelium.

Authors:  Michael Winder; Gunnar Tobin; Daša Zupančič; Rok Romih
Journal:  Biomed Res Int       Date:  2014-08-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.